Furthermore, the blockage of TGF-β by selective peptide inhibitors or its silencing by shRNA or siRNA in B16 cells significantly inhibited tumor growth, metastasis and the sensitivity of melanoma to immunotherapy in vivo [55,56,57]. The gene discussed is TGFB1; the disease is neoplasm.